Skip to main content


Fig. 6 | Breast Cancer Research

Fig. 6

From: Genomic signature of parity in the breast of premenopausal women

Fig. 6

Analyses of the parous differentially expressed genes in breast cancer patients. Genes that were selected for real-time RT-PCR validation were also used for evaluation into breast cancer patients using the cBioPortal tool (, overall Kaplan-Meier survival curve comparing between the cases with and without alterations in these genes. Patients that contained alterations had a median of 143.13 months overall survival while patients without alteration in these genes had median of 168.3 (logrank test p value = 9.09e−5)

Back to article page